Literature DB >> 6136320

A compound follicular-parafollicular cell carcinoma of the thyroid: a new tumor entity?

O Ljungberg, U B Ericsson, L Bondeson, J Thorell.   

Abstract

An unusual thyroid carcinoma is described, showing structural, histochemical and radioimmunologic features of both a follicular and a parafollicular cell carcinoma. Radioimmunoassay revealed high levels of thyroglobulin in the patient's serum and in extracts from metastatic tumor tissue. Immunoreactive thyroglobulin was demonstrated histochemically in tumor cells. On scanning, pulmonary metastases showed uptake of 131I. Somatostatin and neurotensin immunoreactivity was also revealed histochemically in the tumor and a large proportion of the neoplastic cells were argyrophil. Serum calcitonin level was normal and no immunoreactive calcitonin was found in tumor tissue by radioimmunoassay or histochemically. Light microscopy showed cribriform patterns suggestive of follicular carcinoma as well as solid areas reminiscent of medullary carcinoma. Electron microscopy revealed two types of tumor cells. One type had electron dense granules resembling secretory granules characteristic of polypeptide hormone and/or monoamine producing endocrine cells. The other type had no such granules but showed a prominent vesicular rough endoplasmic reticulum similar to that seen in neoplastic follicular cells. The results suggest two alternative possibilities regarding the histogenesis of the tumor. One would be a mixed neoplasm, resulting from a coincidental malignant change in both follicular and parafollicular thyroid cells. The other, more likely alternative would be that the tumor cells are derived from a common stem cell with the potentiality of differentiating into both follicular and parafollicular adult cells. The finding that both thyroglobulin and somatostatin or neurotensin immunoreactivity occurred together in some tumor cells supports the latter possibility and suggests that at least some follicular and parafollicular cells may have a common precursor origin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6136320     DOI: 10.1002/1097-0142(19830915)52:6<1053::aid-cncr2820520621>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  20 in total

1.  Mixed medullary and follicular carcinoma of the thyroid. On the search for its histogenesis.

Authors:  X Matias-Guiu
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

2.  Combined "Mixed Medullary-Follicular" and "Papillary" Carcinoma of the Thyroid with Lymph Node Metastasis.

Authors:  Michio Shimizu; Mitsuyoshi Hirokawa; Virginia A. LiVolsi; Yuji Mizukami; Tanekazu Harada; Tomoo Itoh; Toshiaki Manabe
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

Review 3.  Synchronous medullary, papillary and follicular carcinomas in the same thyroid: case report and review of literature.

Authors:  Daunia Verdi; Gianmaria Pennelli; Francesca Galuppini; Maria Rosa Pelizzo; Antonio Toniato
Journal:  Updates Surg       Date:  2012-04-13

4.  Solid cell nests of the thyroid gland.

Authors:  O Ozaki; K Ito; K Sugino; K Yasuda; T Yamashita; K Toshima; Y Hosoda
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

5.  Intermediate-filament expression in thyroid gland carcinomas.

Authors:  S Schröder; B Dockhorn-Dworniczak; H Kastendieck; W Böcker; W W Franke
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

6.  Intermediate thyroid carcinoma in humans and ultimobranchial tumors in bulls: A comparative morphological and immunohistochemical study.

Authors:  Otto Ljungberg; Per Olle Nilson
Journal:  Endocr Pathol       Date:  1991-03       Impact factor: 3.943

7.  Merged histological types of malignant thyroid tumor: experience and controversy.

Authors:  Liang Huang; Yan Zhang
Journal:  Med Oncol       Date:  2011-01-04       Impact factor: 3.064

8.  Neuroendocrine marker expression in thyroid epithelial tumors.

Authors:  F Satoh; S Umemura; M Yasuda; R Y Osamura
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

9.  Retinoic acid receptor beta2 re-expression and growth inhibition in thyroid carcinoma cell lines after 5-aza-2'-deoxycytidine treatment.

Authors:  F Y Miasaki; A Vivaldi; R Ciampi; L Agate; P Collecchi; A Capodanno; A Pinchera; R Elisei
Journal:  J Endocrinol Invest       Date:  2008-08       Impact factor: 4.256

10.  Coexistence of papillary and medullary carcinoma of the thyroid gland-mixed or collision tumour? Clinicopathological analysis of three cases.

Authors:  S F Lax; A Beham; D Kronberger-Schönecker; W Langsteger; H Denk
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.